Efficacy and safety of adding immune checkpoint inhibitors to first-line standard therapy for recurrent or advanced cervical cancer: a meta-analysis of phase 3 clinical trials
HIGHLIGHTS What: Data sources Frontiers in Immunology Data extraction and assessment of risk of bias Data pertinent to the study […]